172 related articles for article (PubMed ID: 28838148)
1. Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents.
Verschoor CP; Lelic A; Parsons R; Evelegh C; Bramson JL; Johnstone J; Loeb MB; Bowdish DME
J Infect Dis; 2017 Jul; 216(2):191-197. PubMed ID: 28838148
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Varicella Vaccine and Immunologic Predictors of Response in a Cohort of Elderly Nursing Home Residents.
Lelic A; Verschoor CP; Lau VW; Parsons R; Evelegh C; Bowdish DM; Bramson JL; Loeb MB
J Infect Dis; 2016 Dec; 214(12):1905-1910. PubMed ID: 27707807
[TBL] [Abstract][Full Text] [Related]
3. The frequency of interleukin-1β-producing monocytes is significantly associated with varicella-zoster responses of nursing home residents.
Picard E; Bowdish DME; McElhaney JE; Pawelec G; Loeb M; Verschoor CP
Clin Exp Immunol; 2021 Jul; 205(1):63-74. PubMed ID: 33714219
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation patterns are related to co-morbidity status and circulating C-reactive protein levels in the nursing home elderly.
Verschoor CP; McEwen LM; Kobor MS; Loeb MB; Bowdish DME
Exp Gerontol; 2018 May; 105():47-52. PubMed ID: 29032243
[TBL] [Abstract][Full Text] [Related]
5. Immune senescence and vaccines to prevent herpes zoster in older persons.
Levin MJ
Curr Opin Immunol; 2012 Aug; 24(4):494-500. PubMed ID: 22857823
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.
Hata A; Inoue F; Hamamoto Y; Yamasaki M; Fujikawa J; Kawahara H; Kawasaki Y; Honjo S; Koshiyama H; Moriishi E; Mori Y; Ohkubo T
Diabet Med; 2016 Aug; 33(8):1094-101. PubMed ID: 26605507
[TBL] [Abstract][Full Text] [Related]
7. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
8. High Constitutive Interleukin 10 Level Interferes With the Immune Response to Varicella-Zoster Virus in Elderly Recipients of Live Attenuated Zoster Vaccine.
Gershon AA; Brooks D; Stevenson DD; Chin WK; Oldstone MBA; Gershon MD
J Infect Dis; 2019 Apr; 219(8):1338-1346. PubMed ID: 30445431
[TBL] [Abstract][Full Text] [Related]
9. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
10. T-Cell Phenotypes Predictive of Frailty and Mortality in Elderly Nursing Home Residents.
Johnstone J; Parsons R; Botelho F; Millar J; McNeil S; Fulop T; McElhaney JE; Andrew MK; Walter SD; Devereaux PJ; Malek M; Brinkman RR; Bramson J; Loeb M
J Am Geriatr Soc; 2017 Jan; 65(1):153-159. PubMed ID: 27775813
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of the Varicella-Zoster Vaccine in Community-Dwelling Non-robust Elderly Individuals Compared to Robust Elderly Individuals: A Prospective Cohort Study.
Choi JY; Kang MG; Park KU; Park WB; Kim KI; Kim ES; Kim HB; Song KH; Kim CH
J Gerontol A Biol Sci Med Sci; 2019 Jul; 74(8):1225-1230. PubMed ID: 30576411
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus vaccines: effective, but concerns linger.
Liesegang TJ
Can J Ophthalmol; 2009 Aug; 44(4):379-84. PubMed ID: 19606157
[TBL] [Abstract][Full Text] [Related]
13. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
Chlibek R; Pauksens K; Rombo L; van Rijckevorsel G; Richardus JH; Plassmann G; Schwarz TF; Catteau G; Lal H; Heineman TC
Vaccine; 2016 Feb; 34(6):863-8. PubMed ID: 26432913
[TBL] [Abstract][Full Text] [Related]
14. A randomized lot-to-lot immunogenicity consistency study of the candidate zoster vaccine HZ/su.
Strezova A; Godeaux O; Aggarwal N; Leroux-Roels G; Lopez-Fauqued M; Van Damme P; Vanden Abeele C; Vastiau I; Heineman TC; Lal H
Vaccine; 2017 Dec; 35(48 Pt B):6700-6706. PubMed ID: 29079101
[TBL] [Abstract][Full Text] [Related]
15. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
[TBL] [Abstract][Full Text] [Related]
17. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
18. Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents.
Levin MJ; Ginde AA; Schmid DS; Lang N; Canniff J; Schwartz RS; Weinberg A
Vaccine; 2024 Apr; 42(9):2278-2281. PubMed ID: 38423817
[TBL] [Abstract][Full Text] [Related]
19. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
20. Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus.
Hata A; Inoue F; Yamasaki M; Fujikawa J; Kawasaki Y; Hamamoto Y; Honjo S; Moriishi E; Mori Y; Koshiyama H
J Infect; 2013 Sep; 67(3):215-9. PubMed ID: 23603250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
